A variety of medical device innovations and diagnostics have been named by Time as some of the best inventions of 2024.

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

AstraZeneca (AZ) has poached Sean Bohen from Genentech to take the lead role in late stage development of its pipeline drugs. Sean Bohen MD, PhD is currently senior vice president of early ...

A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s new drug, Wainzua, has been recommended for approval in the EU for treating hereditary transthyretin-mediated amyloidosis, providing a ...

In a report released today, Peter Welford from Jefferies maintained a Hold rating on AstraZeneca (AZN – Research Report), with a price target of £114.00. The company’s shares opened today at ...

AstraZeneca reaffirmed its commitment to combating infectious ... In addition, vaccine effectiveness data on FluMist, the only self-administered flu vaccine approved in the US, will be presented. Real ...

FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for self-administration by patients aged 18-49. FluMist is the first influenza ...